English
Specials
MoneycontrolBe a PRO
you are here: HomeNewsBusinessMoneycontrol Research
  
  1
Last Updated Last Updated : January 31, 2021 / 01:23 PM IST | Source: Moneycontrol.com

Cipla — Large part of COVID opportunity has played out

In the US market, Albuterol opportunity remains a key lever for Cipla at least till the time Perrigo re-enters although in terms of market share, the drugmaker may be close to maturity

Anubhav Sahu

To view the full content of this article, you have to be a Pro:

  • Already a Moneycontrol Pro subscriber?
    Login now »
    Or
    Open in App
  • Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:

What's included:

  • Ad free experience across Platforms
  • 230+ exclusive stories per month
  • Sharpest Opinions & Actionable Insights
  • Exclusive Research & Expert Technical Analysis
  • Daily Newsletter
  • 20+ Technical Picks every week
  • Recovery Tracker
  • Exclusive webinars on varied topics
  • Weekly wrap up and much more!!!
Subscribe to PRO and get unlimited access to premium content at Rs.33/- per month. Use code SUPERPRO